Wrinkle Injection With Autologous Platelet Rich Plasma Study (WIPES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01078493|
Recruitment Status : Withdrawn (Protocol revision necessary.)
First Posted : March 2, 2010
Last Update Posted : September 26, 2016
|Condition or disease||Intervention/treatment||Phase|
|Wrinkles||Device: MyCells® (injection of platelet rich plasma)||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Phase 1 Study of Intradermal Injection of Autologous Platelet Rich Plasma for Facial Wrinkles|
|Study Start Date :||February 2010|
|Primary Completion Date :||February 2012|
|Study Completion Date :||May 2012|
Device: MyCells® (injection of platelet rich plasma)
- Total Wrinkle Length [ Time Frame: 3 months ]All visible wrinkles are measured and the length is summed up to give the Total Wrinkle Length. Comparison of pre treatment and post treatment Total Wrinkle Length will be studied.
- Side effect / Adverse Event [ Time Frame: 3 months ]Side Effects / Adverse Events to be monitored include allergic reaction, nerve injury and cavernous sinus thrombosis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01078493
|Life Source Medical Centre @ Novena Medical Center|
|Singapore, Singapore, 307506|
|Principal Investigator:||Kok Leong Tan, MBBS||Life Source Medical Centre @ Novena Medical Center|